Advertisement
Immune recognition of OxLDL in atherosclerosis
John F. Kearney
Department of Microbiology, Division of Developmental and Clinical Immunology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA.
Phone: (205) 934-6557; Fax: (205) 934-1875; E-mail: john.kearney@ccc.uab.edu.
Find articles by Kearney, J. in: JCI | PubMed | Google Scholar
Published June 15, 2000 - More info
J Clin Invest. 2000;105(12):1683–1685. https://doi.org/10.1172/JCI10426.
© 2000 The American Society for Clinical Investigation
The innate nonadaptive immune system plays a crucial role in the acute response to infectious agents. Within hours of exposure to an invading microorganism, well before adaptive cellular or humoral immune responses are engaged, the bulk of most infections is cleared by cells and molecules that bind with broad specificity to structures common to various pathogens. Only when infectious organisms break through these barriers do antigen receptor–bearing effector cells of the adaptive immune system come into play, ensuring that these organisms are cleared.
Blurring the distinction between the innate and the cognate aspects of the immune system are subsets of lymphocytes that recognize pathogenic determinants and are expressed even in immunologically naive animals (1). The significance of these lymphocytes is shown by the strong protection, elicited by T-independent natural IgM antibody, against certain viral and bacterial infections (2). The B- or T-cell receptors of these lymphocytes often contain highly conserved sequences, arise reproducibly in all mice, and do not depend on exogenous antigen for their generation. In this respect, they constitute an “evolutionary memory” and form a bridge between pattern recognition molecules — mannose receptors, macrophage scavenger receptors, and other similar molecules (3) — and the classic adaptive responses, which generally require T-cell help both to hone the specificity of the molecular interaction and to maintain immunological memory. These evolutionarily conserved responses to ubiquitously expressed microbial components are not confined to B cells, as there are numerous examples of αβ and γδ T cells that express canonical receptors to microbial components (4, 5).
In this issue of the JCI, Shaw et al. (6) show that these structurally distinct receptors functioning in different branches of the immune system nonetheless share patterns of ligand specificity. This provocative finding not only suggests mechanisms that may influence the progression of the disease, but also identifies a hitherto unknown function of an antibody response to a pathogenic bacterium.
-
Natural antibodies in atherosclerotic mice
Shaw et al. (6) now report that this particular antibody has clearly defined specificity for modified LDL determinants. In ApoE–/– mice, the development of atherosclerosis is paralleled by increasing titers of antibodies to OxLDL. Using hybridomas and a comprehensive series of antibody specificity tests, these authors show that a major portion of the response can be attributed to the expansion and activation of independently arising T15+ clones, and they confirm this finding with molecular analyses (6). Although the anti-PC response has been studied for more than 30 years, this study appears to provide the first clues to the nature of the ligand that selects for T15+ clones during development. As shown in Figure 1, other B-cell clones also respond to modified lipoprotein determinants, but the T15 response predominates in most mice. Interestingly, the anti-PC responses employ different Vκ regions but the same Jκ5 region. Jκ5 is located at the 3′-most end of the Jκ locus, and its use has been interpreted as an indication that the progenitors of these B cells have revised their receptors during early development to escape from self-reactivity (14). This model suggests a possible mechanism by which multispecific T15+ B-cell clones may have been positively selected. These clones, which react not only with OxLDL and bacterial PC but also with apoptotic cells, may have been selected by interaction with apoptotic debris at sites of B-cell development in fetal liver and bone marrow (15), in a process that could involve receptor editing before or during the proliferation of specific B cells. Although the present authors have previously shown (16, 17) that deliberate immunization of hypercholesterolemic rabbits or mice expressing high levels of OxLDL lessens atherosclerosis, the role of these autoantibodies against OxLDL needs more evaluation.
Figure 1Potential role of OxLDL and ApoE in autoantibody production. Top: Under normal circumstances, the newly formed IgM+ B-cell population in the perinatal bone marrow or fetal liver can respond to millions of specific antigenic structures. Included in this population are anti-PC clones, some of which carry the T15 idiotype. In the selection step, PC epitopes on apoptotic material or OxLDL (selecting Ag) may enrich for T15/PC-specific B cells. The degree to which this occurs would be limited by the efficiency of debris-scavenging by macrophages or by the availability of ApoE. Additionally, these T15 clones may be stimulated to differentiate by the normally regulated amounts of PC or OxLDL (activating Ag). Bottom: In the absence of ApoE, accumulated OxLDL may promote a still more profound enrichment for T15 clones or may stimulate existing clones to differentiate into T15-producing (natural antibody–producing) plasma cells. Either possibility would give rise to the high levels of anti-OxLDL antibodies observed in the ApoE–/– mice. Circles represent B cells; ovals represent mature antibody-secreting plasma cells. Blue, αPC; yellow, T15/PC.
The exuberant response of the T15+ clones in ApoE–/– mice is clearly antigen-driven, and the antigens appear to be oxidized phospholipids and/or their protein counterparts. It will be important to determine the fine specificity and the affinity of their binding to each of these species of modified LDL. Additionally, mechanisms involved in the activation of these B cells needs evaluation. Normally, T15+ B cells can be triggered into proliferation and IgM antibody production in a T-independent fashion. The role of T cells in the response is not yet clear, nor is it known whether switching to IgG isotypes occurs. This possibility could be of considerable importance for understanding atherosclerotic plaque formation, since foam cells may use Fc receptors to take up OxLDL complexed with IgG but not IgM antibodies. Conceivably, then, chronic infection with organisms expressing PC may induce synthesis of anti-PC antibodies of IgM or even IgG isotypes, which could influence the disease process. Since the anti-PC B-cell repertoire changes during the life of the organism, the participation of natural IgM anti-PC antibodies in the disease process may vary with age (18).
One way to test these admittedly speculative ideas would be to compare the effects of T15+ antibody levels in different mouse models of atherosclerosis. In ApoE–/– mice, the disease process begins very early, progresses steadily, and does not require high levels of dietary cholesterol. Conversely, in LDL receptor–deficient (LDLR-deficient) mice, the beginnings of atherosclerosis are not evident unless animals receive a specific diet (19). How might the production of anti-OxLDL antibodies — and the natural history of the disease — be affected by providing this diet to LDLR–/– mice only after the critical perinatal period when T15+ clones become selected? Similarly, since OxLDL has been found in fetal arteries of ApoE–/– animals (20), this ligand may be involved in the positive selection of the emerging T15+ clones (Figure 1). The increased levels of OxLDL in the ApoE–/– mice may amplify the normal selection process, resulting in a greatly expanded pool of these cells in the adult. The current work (6) shows that a highly conserved antibody response to PC can affect the metabolism of modified LDL, but whether it contributes to atherosclerosis, either promoting or ameliorating this condition, remains to be determined.
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)